Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R2686 H-DL-Pyr-DL-Phe-DL-xiThr-DL-Asp-DL-Val-DL-Asp-DL-Cys(1)-DL-Ser-DL-Val-DL-Ser-DL-Lys-DL-Glu-DL-Cys(2)-DL-Trp-DL-Ser-DL-Val-DL-Cys(3)-DL-Lys-DL-Asp-DL-Leu-DL-Phe-Gly-DL-Val-DL-Asp-DL-Arg-Gly-DL-Lys-DL-Cys(1)-DL-Met-Gly-DL-Lys-DL-Lys-DL-Cys(2)-DL-Arg-DL-Cys(3)-DL-Tyr-DL-Gln-OH.TFA 4345 C181H275F3N50O57S7
R2687 PSMA-11 2,2,2-Trifluoroacetate 1061 C46H63F3N6O19
R2688 Danegaptide Hydrochloride 327.76 C14H18ClN3O4
R2689 Gpda 464.5 C20H24N4O7S
R2690 Cyclo(his-pro) (TFA) 348.28 C13H15F3N4O4
R2691 Anserine 240.26 C10H16N4O3
R2692 MM-401 Tfa 700.7 C31H47F3N8O7
R2693 Buserelin 1239.4 C60H86N16O13
R2694 D-Ile-Pro-Arg p-nitroanilide dihydrochloride 577.5 C23H38Cl2N8O5
R2695 Macimorelin Acetate 534.6 C28H34N6O5
R2696 Polymyxin B2 1189.5 C55H96N16O13
R2697 MC-VC-Pab-NH2 tfa 772.8 C33H47F3N8O10
R2698 1-Methylnicotinamide 137.16 C7H9N2O+
R2699 Pyrrolo(1,2-a)pyrazine-1,4-dione, hexahydro-3-(1-methylethyl)- 196.25 C10H16N2O2
R2700 Met-Gly-Pro-AMC 460.5 C22H28N4O5S
R2702 Pro-Pro-Pro 309.36 C15H23N3O4
R2703 Polymyxin E1 (sulfate) 1267.5 C53H102N16O17S
R2704 Prosomatostatin 3148.6 C137H207N41O39S3
R2705 PD080645 4564 C196H340F3N63O56S
R2706 Gozetotide 947 C44H62N6O17